NTRA
Natera IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$31.15B
P/E Ratio
—
EPS
$-1.62
Beta
1.54
52W High
$256.36
52W Low
$131.81
50-Day MA
$206.46
200-Day MA
$205.21
Dividend Yield
—
Profit Margin
-9.05%
Forward P/E
—
PEG Ratio
0.00
About Natera Inc
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
Fundamentals
| Revenue (TTM) | $2.50B |
| Gross Profit (TTM) | $1.63B |
| EBITDA | $-267.58M |
| Operating Margin | -12.40% |
| Return on Equity | -15.00% |
| Return on Assets | -9.12% |
| Revenue/Share (TTM) | $18.07 |
| Book Value | $12.43 |
| Price-to-Book | 17.70 |
| Price-to-Sales (TTM) | 12.45 |
| EV/Revenue | 12.22 |
| EV/EBITDA | -26.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 38.80% |
| Shares Outstanding | $143.22M |
| Float | $138.92M |
| % Insiders | 3.02% |
| % Institutions | 95.84% |
Historical Volatility
HV 10-Day
47.81%
HV 20-Day
50.71%
HV 30-Day
59.87%
HV 60-Day
58.53%
HV Rank
91.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($260.05 target)
4
Strong Buy13
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026